Optimi Health, a Canada-based pharmaceuticals maker specializing in MDMA and psilocybin, raised $15 million by offering 2.4 million shares at $6.25, within the $6 to $8 range. The company offered 0.1 million fewer shares than anticipated. It originally filed to ...read more
One small IPO and two SPACs debuted this week. Nine IPOs and four SPACs submitted initial filings. Singapore-based swim lesson provider Fitness Champs Holdings (FCHL) priced its US IPO at the bottom of the range to raise $15 million at a $68 million market...read more
Optimi Health, a Canada-based pharmaceuticals maker specializing in MDMA and psilocybin, filed on Friday with the SEC to raise up to $25 million in an initial public offering. Optimi Health is currently listed on the Canadian Securities Exchange (OPTI), the...read more
Canada-based psychedelics manufacturer Optimi Health prices US IPO at $6.25, within the range
Optimi Health, a Canada-based pharmaceuticals maker specializing in MDMA and psilocybin, raised $15 million by offering 2.4 million shares at $6.25, within the $6 to $8 range. The company offered 0.1 million fewer shares than anticipated. It originally filed to ...read more
Canada-based psychedelics manufacturer Optimi Health sets terms for $15 million US IPO
...read more
US IPO Weekly Recap: 1 small IPO debuts as more filers enter the pipeline
One small IPO and two SPACs debuted this week. Nine IPOs and four SPACs submitted initial filings. Singapore-based swim lesson provider Fitness Champs Holdings (FCHL) priced its US IPO at the bottom of the range to raise $15 million at a $68 million market...read more
Canada-based psychedelics manufacturer Optimi Health files for a $25 million US IPO
Optimi Health, a Canada-based pharmaceuticals maker specializing in MDMA and psilocybin, filed on Friday with the SEC to raise up to $25 million in an initial public offering. Optimi Health is currently listed on the Canadian Securities Exchange (OPTI), the...read more